Revenue (Annual) Chart

View Revenue (Annual) for RHHBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1991. Start Trial.
Date Value
December 31, 2025 74.07B
December 31, 2024 68.69B
December 31, 2023 65.34B
December 31, 2022 66.26B
December 31, 2021 68.69B
December 31, 2020 62.14B
December 31, 2019 61.85B
December 31, 2018 58.09B
December 31, 2017 54.15B
December 31, 2016 51.34B
December 31, 2015 50.00B
December 31, 2014 51.85B
December 31, 2013 50.46B
December 31, 2012 48.50B
December 31, 2011 47.97B
December 31, 2010 45.55B
December 31, 2009 45.18B
December 31, 2008 42.13B
Date Value
December 31, 2007 38.44B
December 31, 2006 33.55B
December 31, 2005 28.49B
December 31, 2004 23.76B
December 31, 2003 23.21B
December 31, 2002 19.11B
December 31, 2001 17.27B
December 31, 2000 16.97B
December 31, 1999 18.33B
December 31, 1998 17.02B
December 31, 1997 12.94B
December 31, 1996 12.87B
December 31, 1995 12.58B
December 31, 1994 10.87B
December 31, 1993 9.687B
December 31, 1992 9.267B
December 31, 1991 7.979B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Novartis AG 54.81B
AstraZeneca PLC 58.88B
Eli Lilly & Co. 65.18B
Merck & Co., Inc. 64.93B
Pfizer Inc. 62.58B